New genetic test improves ovarian cancer treatment miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
A new genetic test developed at the University of Helsinki and Helsinki University Hospital helps identify ovarian cancer patients who benefit from PARP inhibitors, a type of targeted drug that could be effective against ovarian cancer.
HELSINKI, Jan. 11 (Xinhua) A new genetic test developed at the University of Helsinki and Helsinki University Hospital helps identify ovarian cancer patients who benefit from PARP inhibitors, a type of targeted drug that could be effective against ovarian cancer, the University of Helsinki said in a press release on Wednesday.